Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Vivos Therapeutics
Acquired Company
SOD Sciences
DelawareFloridaBiotechnologyHealth CareTherapeuticsBiotechnologyHealth CareDescription
Vivos Therapeutics, Inc. has entered into a Mutual Stock Purchase and Asset Exchange Agreement to acquire a minority equity interest in SOD Sciences, Inc. The agreement includes a 50% co-ownership interest in SOD's pseudohypoxia early-warning test and related intellectual property. The transaction is expected to enhance Vivos' product offerings in the sleep therapy market. Closing of the transaction is scheduled for October 16, 2026.
Fundz sees it the moment Vivos Therapeutics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired SOD Sciences?
SOD Sciences was acquired by Vivos Therapeutics, based in Delaware. The deal was reported on October 19, 2026. Vivos Therapeutics, Inc. is a Delaware corporation focused on innovative technologies for treating breathing disorders. Vivos Therapeutics is publicly traded (VVOS) and operates in Biotechnology.
When did Vivos Therapeutics acquire SOD Sciences?
Vivos Therapeutics's acquisition of SOD Sciences was reported on October 19, 2026. Vivos Therapeutics, Inc. has entered into a Mutual Stock Purchase and Asset Exchange Agreement to acquire a minority equity interest in SOD Sciences, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does SOD Sciences do?
SOD Sciences, Inc. is a Florida corporation that specializes in innovative health testing and treatment protocols. The company is known for its ReBalU Protocol, a test/treat/retest platform that includes patent filings for a pseudohypoxia early-warning test. It is privately held, operating in Biotechnology, and is based in Florida.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.